Dentistry Faculty
Cairo, Egypt
NCT Number: NCT03341260
The purpose of this study is to assess the effect of preoperative a single-dose of 50 mg diclofenac potassium on postoperative endodontic pain in mandibular molars with symptomatic irreversible pulpitis.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Phase 2 / Phase 3
Cairo, Egypt
Patients with moderate-to-severe preoperative pain are selected. Patients receive either a single-dose of 50 mg diclofenac potassium (group A) or a placebo tablet as a control (group B). All patients receive the assigned premedication one hour before single-visit root canal treatment. Postoperative endodontic pain is measured at the following time points: 6 , 12,24,48 h after treatment. The incidence of analgesic intake is also recorded.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A 50 mg tablet of the medication to be taken one hour before initiation of endodontic treatment.
A placebo will be taken one hour before initiation of endodontic treatment.
Time frame: Up to 2 days after endodontic treatment
Pain after completion root canal treatment measured by Heft-parker visual analogue scale.
Time frame: Up to 2 days after endodontic treatment
The incidence of analgesic intake is recorded
Cairo University
Other
Effect of Preoperative, Single-dose Diclofenac Potassium on Postoperative Endodontic Pain in Patients With Symptomatic Irreversible Pulpitis: A Double Blind Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07355140
Dental Pulp Diseases, Pulpitis
Caracas, DC, Venezuela
View Trial DetailsNCT07271654
Neurologic Manifestations, Pain
Swat, Pakistan
View Trial DetailsNCT07270159
Irreversible Pulpitis with Apical Periodontitis, Neurologic Manifestations
Karachi, Sindh, Pakistan
View Trial DetailsNCT06760312
Dental Pulp Diseases, Inflammation
Izmir, Çiğli, Turkey (Türkiye)
View Trial Details